You just read:

Sunovion Pharmaceuticals Canada Inc. Announces the Launch of Once-Daily LATUDA™ (lurasidone HCl) for the Treatment of Patients with Schizophrenia

News provided by

Sunovion Pharmaceuticals Canada Inc.

Sep 17, 2012, 09:00 ET